Improved Arterial Compliance by a Novel Advanced Glycation End-Product Crosslink Breaker
Top Cited Papers
- 25 September 2001
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Circulation
- Vol. 104 (13) , 1464-1470
- https://doi.org/10.1161/hc3801.097806
Abstract
Background Arterial stiffening with increased pulse pressure is a leading risk factor for cardiovascular disease in the elderly. We tested whether ALT-711, a novel nonenzymatic breaker of advanced ...Keywords
This publication has 26 references indexed in Scilit:
- Pulse pressure—a review of mechanisms and clinical relevanceJournal of the American College of Cardiology, 2001
- Therapeutic studies and arterial stiffness in hypertensionJournal Of Hypertension, 2000
- Drug treatment of hypertensionJournal Of Hypertension, 2000
- Is there a preferred antihypertensive therapy for isolated systolic hypertension and reduced arterial compliance?Current Hypertension Reports, 2000
- The Placebo Effect and White Coat Effect in Isolated Systolic Hypertension and Systo-diastolic hypertensionBlood Pressure, 2000
- An agent cleaving glucose-derived protein crosslinks in vitro and in vivoNature, 1996
- Diminished arterial elasticity in diabetes: association with fluorescent advanced glycosylation end products in collagenCardiovascular Research, 1993
- Role of Glycation in AgingAnnals of the New York Academy of Sciences, 1992
- Aortic compliance in human hypertension.Hypertension, 1989
- Antihypertensive effect of sustained-release isosorbide dinitrate for isolated systolic systemic hypertension in the elderlyThe American Journal of Cardiology, 1987